ACACB and obesity disorder: Conversely, administration or overexpression of FGF-19 in mice provided protection from diet-induced obesity as a result of increased hepatic fatty acid oxidation via suppression of acetyl-CoA carboxylase 2 and stearoyl-CoA desaturase 1 [67,68].